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Natural killer (NK) cells are important effector
cells in the control of infections. The cellular
and molecular signals required for NK cell ac-
tivation in vivo remain poorly defined. By us-
ing a mouse model for the inducible ablation
of dendritic cells (DCs), we showed that the
in vivo priming of NK cell responses to viral and
bacterial pathogens required the presence of
CD11chigh DCs. After peripheral Toll-like recep-
tor (TLR) stimulation, NK cells were recruited to
local lymph nodes, and their interaction with
DCs resulted in the emergence of effector NK
cells in the periphery. NK cell priming was de-
pendent on the recognition of type I IFN signals
by DCs and the subsequent production and
trans-presentation of IL-15 by DCs to resting
NK cells. CD11chigh DC-derived IL-15 was nec-
essary and sufficient for the priming of NK cells.
Our data define a unique in vivo role of DCs for
the priming of NK cells, revealing a striking and
previously unappreciated homology to T lym-
phocytes of the adaptive immune system.
INTRODUCTION
Natural killer (NK) cells are effector lymphocytes of the
rapidly acting innate immune system that mediate cellular
cytotoxicity and produce cytokines and chemokines (Trin-
chieri, 1989). NK cells play an essential role in the recogni-
tion and eradication of virally infected cells and tumors
(Trinchieri, 1989). In contrast to T lymphocytes of the
adaptive immune system, which need to be primed for
effector functions by cognate interaction with antigen-
presenting dendritic cells (DCs) in lymph nodes (LN) (Ban-
chereau and Steinman, 1998), NK cells were originally
identified as blood-borne or tissue-resident ‘‘naturally
active’’ cells that readily display effector functions upon
encountering infected or transformed cells (Herberman
et al., 1975; Kiessling et al., 1975; Trinchieri, 1989). How-
ever, NK cells from mice and humans show minimal effec-tor functions (cytotoxicity, cytokine production) when
incubated in vitro with tumor target cells or when directly
triggered via their stimulatory receptors, suggesting that
resting NK cells require additional signals for their activa-
tion (Bryceson et al., 2006). Indeed, investigators usually
treat mice with Toll-like receptor (TLR) ligands or cyto-
kines (e.g., type I interferons or their synthetic inducers)
or culture NK cells ex vivo in the presence of cytokines
(e.g., IL-2, IL-15) to elicit detectable effector functions
prior to in vitro analyses of NK cell responses (Bryceson
et al., 2006; Djeu et al., 1979; Gidlund et al., 1978).
Given the increasingly appreciated role of innate
immune cells and NK cells for protective therapeutic strat-
egies, it is of considerable interest to understand the
molecular and cellular requirements that lead to NK cell
activation in vivo. Some reports have suggested that NK
cells, like myeloid cells, directly recognize pathogen-
associated molecules via NK cell-expressed TLR (Hart
et al., 2005; Schmidt et al., 2004; Sivori et al., 2004). In ad-
dition, numerous in vitro studies have focused on a poten-
tial role of myeloid cells for the activation of NK cells and
demonstrated that TLR-stimulated bone marrow (BM)-
or monocyte-derived DCs or macrophages from humans
or mice contribute to NK cell activation (Andoniou et al.,
2005; Baratin et al., 2005; Chambers et al., 1996; Ferlazzo
et al., 2004; Fernandez et al., 1999; Gerosa et al., 2002;
Jinushi et al., 2003a; Krug et al., 2004). Further, both
cytokines and NK cell receptor-ligand interactions have
been implicated in the in vitro activation of NK cells by
BM- or monocyte-derived DCs. Indeed, IFN-g production
of mouse and human NK cells after coculture with patho-
gen-stimulated DCs is diminished in the absence of IL-12
whereas cytotoxicity is dependent on the presence of type
I IFNs (Andoniou et al., 2005; Ferlazzo et al., 2004).
IL-15 is an important factor for the survival and the pro-
liferation of NK cells during coculture with DCs (Ferlazzo
et al., 2004). Ma and colleagues have suggested a pivotal
role of DC-expressed IL-15 receptor a chain (IL-15Ra)
trans-presenting IL-15 both for killing and for IFN-g pro-
duction by NK cells in vitro (Koka et al., 2004). It is currently
unknown whether IL-15 mediates NK cell activation
in vivo. In addition to cytokines, ligands for the stimulatory
NKG2D receptor expressed by myeloid cells have been
implicated in NK cell stimulation by DCs (Andoniou et al.,Immunity 26, 503–517, April 2007 ª2007 Elsevier Inc. 503
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these factors contribute to NK cell activation depending
on the type of infection, the availability of cytokines, and
the expression of stimulatory ligands, or whether some
of these signals are nonredundant requirements for the
in vivo induction of NK cell effector functions.
A role for myeloid cells in the induction of NK cell re-
sponses in vivo has been considered in previous reports
(Andrews et al., 2003; Cudkowicz and Yung, 1977; Djeu
et al., 1979; Fernandez et al., 1999). However, previous
data were based on unspecific approaches to deplete
DCs (e.g., depletion of all CD8a+ cells including CD8aa+
DCs) and did not analyze NK cell effector functions in
the absence of DCs (Andrews et al., 2003; Fernandez
et al., 1999). Thus, the role of DCs or other myeloid cells
for the acquisition of NK cell effector responses (cytokine
production, cytotoxicity, and control of pathogens) in vivo
remains undefined because until recently, the specific ab-
lation of DCs or macrophages was not feasible (Jung et al.,
2002).
The spatiotemporal organization of NK cell responses
and of potential NK cell-DC interaction in vivo is unknown.
It has been proposed that NK cells interact with DCs in
inflamed peripheral tissues (Moretta, 2002). Others have
shown that NK cells are in intimate contact with DCs in
secondary lymphoid organs (Bajenoff et al., 2006; Fer-
lazzo et al., 2004) and that naive NK cells can be recruited
to the draining LN (DLN) after local injection of BM-derived
TLR-stimulated DCs or tumors (Chen et al., 2005; Martin-
Fontecha et al., 2004). However, it is unknown whether the
interaction of resting NK cells with DCs in secondary lym-
phoid organs is required for the emergence of peripheral
effector NK cells.
By using a genetic approach for the inducible ablation of
DCs, we investigated the role of DCs in the acquisition of
NK cell effector functions in vivo. Here we show that NK
cell responses to viral and bacterial pathogens in vivo de-
pend on their interaction with CD11chigh DCs and on type I
IFN signals received by DCs. Marginal zone and/or metal-
lophilic macrophages, which are also ablated in these
mice, were dispensable for the acquisition of NK cell ef-
fector functions. Type I IFN-experienced DCs produced
and trans-presented IL-15 in vivo, a signal necessary
and sufficient for NK cell priming. Our data indicate that
NK cells are not constitutively braced to respond accord-
ing to the balance between activating and inhibiting sig-
nals. Instead, naive NK cells need to acquire effector func-
tions by interacting with DCs in secondary lymphoid
organs, revealing a striking homology to T lymphocytes
of the adaptive immune system.
RESULTS
NK Cell Priming Requires the Presence
of CD11chigh DCs
To assess whether the acquisition of NK cell effector
functions requires the presence of DCs, we employed a
transgenic (tg) mouse model, which allows the inducible
ablation of all conventional CD11chigh DCs including the504 Immunity 26, 503–517, April 2007 ª2007 Elsevier Inc.CD8aa+ subset (Jung et al., 2002). In these mice, the sim-
ian diphtheria toxin receptor (DTR) is expressed as a fusion
protein with green fluorescent protein (GFP) under the
transcriptional control of the CD11c promoter. Injection
of diphtheria toxin (DT) led to the ablation of all CD11chigh
DCs (see Figure S1A in the Supplemental Data available
online) but did not affect relative (Figure S1A) or absolute
NK cell numbers (Figure S1B) or the composition of NK
cell subsets (Figure S1C). CD11cint cells, like plasmacy-
toid (p)DCs (Figure S1A), and CD11cneg cells (T cells, B
cells) were also unaffected in CD11c DTR tg mice after
DT injection (Jung et al., 2002; Probst et al., 2005). To for-
mally exclude any direct functional impact of DT on NK
cells in CD11c DTR tg mice, we generated mixed BM chi-
meric mice in which the NK cell compartment was derived
in equal parts from CD11c DTR tg and non-tg littermate
BM cells. After DT injection and TLR stimulation, NK cells
derived from CD11c DTR tg-derived stem cells were func-
tionally indistinguishable from NK cells derived from the
BM of littermate control mice (Figure S1D). Thus, CD11c
DTR tg mice are a suitable in vivo model system to study
NK cell activation in the absence of CD11chigh DCs.
It is widely appreciated that infections strongly enhance
NK cell effector functions, but it remained unknown
whether DCs are required in this process in vivo. Innate
immune recognition of viruses and other microbes is me-
diated to a large extent by TLR interacting with conserved
microbial molecules (Medzhitov and Janeway, 2002). As
an initial assessment of the contribution of CD11chigh
DCs to NK cell responses after microbial infections
in vivo, we injected TLR ligands into DC-ablated and con-
trol mice and analyzed NK cell effector functions. NK cells
isolated from TLR-stimulated mice produced IFN-g when
directly triggered by the activating NK cell receptors NKR-
P1C (also known as NK1.1), NKG2D, or Ly49D (Figure 1A),
and they killed (Figure 1B) or produced cytokines (Fig-
ure 1C) in response to tumor target cells expressing a stim-
ulatory NKG2D ligand. Strikingly, NK cells isolated from
CD11chigh DC-ablated mice displayed strongly reduced
effector functions after TLR stimulation in vivo (Figures
1A–1C). Similar results were obtained with various other
NK cell targets including YAC-1 or RMA-S cells (data not
shown). After TLR stimulation, NK cells isolated from
CD11chigh DC-ablated mice did not accumulate granzyme
B (Figure 1D) and showed impaired upregulation of
CD69 (Figure S2). Notably, nonmicrobial stimulation of
CD11chigh DCs by injection of an agonistic antibody spe-
cific for CD40 but not an isotype control antibody (data
not shown) stimulated NK cell activation that was DC de-
pendent (Figures 1B–1D and Figure S2). Similar results
were obtained with CD11c DTR tg mice deficient for re-
combination-activating gene 1 (Rag1/), which lack all
T and B cells but have a functional NK and myeloid cell
compartment (Figures 1B and 1C). These data demon-
strate that B and/or T cells do not substantially contribute
to DC-mediated NK cell activation.
NK cells isolated from TLR-stimulated mice fail to lyse
RMA cells (Karre et al., 1986), but further enhancement
of the stimulatory signal by preincubating RMA cells with
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(A–D) CD11c DTR tg mice or Rag1/ CD11c DTR tg were injected with diphtheria toxin (DT) to ablate all CD11chigh DCs (open symbols). Control mice
received PBS injections (solid symbols). 1 day after DT injection, mice were injected i.p. with the indicated TLR ligands or an agonistic CD40 antibody
or with control injections of PBS or control Ig (not shown). NK cell effector functions were determined 18 hr after stimulation.
(A) IFN-g production by highly purified splenic NK cells in response to immobilized anti-NKR-P1C (NK1.1), anti-Ly49D, and anti-NKG2D.
(B and C) Cytotoxicity (B) and IFN-g production (C) of NK cells against RMA-S-H60 targets. Similar results were obtained with RMA-S and YAC-1
targets (data not shown). The percentage of NK1.1+CD3 cells in the lymphocyte populations was determined prior to the cytotoxicity assay, and
lymphocyte numbers were adjusted to contain the same number of NK cells. Thus, an NK cell:target ratio of 6:1 is equivalent to a 100–200:1 sple-
nocyte:target ratio.
(D) Granzyme B (gzmB) expression by NK cells. IFN-g production and granzyme B expression were determined by intracellular cytokine staining and
electronic gating on NK cells. Shown are mean ± SD (n = 3), and results are representative of at least three separate experiments.
(E) Groups of CD11c DTR tg mice were injected with DT (open squares). Control mice received PBS injections (solid squares). Some mice received
two injections of asialo-GM1 antiserum to deplete all NK cells (open circles), and control mice received equal amounts of normal rabbit serum (NRS).
1 day later, mice were injected with TLR3 ligand or PBS. Antibody-dependent cytotoxicity (ADCC) of NK cells was evaluated against RMA cells
preincubated with Thy1.2 or control antibodies 18 hr after TLR stimulation. Results are representative of three independent experiments.Thy1 antibodies led to NK cell-mediated antibody-depen-
dent cellular cytotoxicity (ADCC), which required the pres-
ence of DCs during TLR stimulation in vivo (Figure 1E). To
formally exclude a contribution of CD11c+ cells of nonhe-
matopoietic origin, we lethally irradiated non-tg B6 mice
(CD45.1) and reconstituted them with BM from CD11c
DTR tg mice (CD45.2) (Zammit et al., 2005). As in CD11c
DTR tg mice, TLR or anti-CD40 stimulation of the BM-
reconstituted mice failed to induce NK cell effector func-
tions when CD11chigh DCs were ablated (data not shown).
In most cases, NK cells from TLR-stimulated mice did
not spontaneously produce IFN-g ex vivo or in situ (Fig-
ure 1A and data not shown). However, these NK cells
displayed potent effector functions when their stimulatory
receptors were triggered, demonstrating that TLR-stimu-
lated DCs ‘‘prime’’ (rather than activate) NK cells in vivo.
Thus, the presence of DCs is required for the priming ofNK cells, endowing them with effector functions in re-
sponse to TLR stimulation or CD40-mediated stimulation
of DCs.
NK Cell Priming Does Not Require the Presence
of Macrophage Subpopulations
We considered a role for macrophages in the priming of
NK cells because the analysis of DT-injected CD11c
DTR tg mice revealed that, in addition to CD11chigh DCs,
splenic ER-TR9+ marginal zone (MZM) and MOMA-1+
metallophilic macrophages (MM) as well as their sinusoi-
dal counterparts in LNs were ablated. However, CD11b+
F4/80+ macrophages are unlikely to contribute to the
priming of NK cells because they were not affected in
DT-treated CD11c DTR tg mice, although a transient
downregulation of the F4/80 antigen was observed
(Probst et al., 2005). CD11chigh DCs were restored 3–4Immunity 26, 503–517, April 2007 ª2007 Elsevier Inc. 505
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(A) Schematic overview of experimental procedures.
(B) Immunophosphatase staining of splenic sections from TLR-stimulated mice for the indicated cell-surface markers 2 or 5 days after DT injection.
Original magnification, 503.
(C–E) Groups of CD11c DTR tg mice were injected with DT (open symbols). Control mice received PBS injections (solid symbols). 1 day or 4 days later,
mice were injected with the indicated TLR ligand and analyzed 18–24 hr later.
(C) The percentage of CD11chigh MHC-II+ cells in the spleen was evaluated by flow cytometry analysis at the indicated time points after DT injection.
(D and E) Cytotoxicity (D) and IFN-g production (E) of splenic NK cells were determined at the indicated time points after DT injection against
RMA-S-H60 targets. Similar results were obtained with YAC-1 targets (data not shown). Shown are mean ± SD (n = 3) and results are depicted
from two independent experiments, which are representative of three experiments performed.
(F) Dendritic cells but not macrophages rescue NK cell priming. CD11c DTR tg mice were injected i.v. with 3–10 3 106 BM-derived DCs or macro-
phages 1 day prior to DC ablation. 1 day later, mice were injected with TLR3 ligand, and cytotoxicity (left) and IFN-g (right) production of NK cells were
assayed against RMA-S-H60 cells 18 hr after TLR stimulation. Similar results were obtained with YAC-1 targets (data not shown). Mean ± SD (n = 3–4)
is shown and results are representative of five (cytotoxicity data) or three (IFN-g data) separate experiments. nd, not done; Mph, macrophages.days after DT injection, whereas MZM and MM remain ab-
sent for more than 7 days (Jung et al., 2002; Probst et al.,
2005). This differential kinetics of repopulation allowed us
to experimentally address the question of whether MZM
and/or MM are involved in NK cell priming (Figure 2A). At
day 2 after DT injection, both DCs and the MZM and
MM populations were ablated whereas red pulp macro-
phages were unaffected (Figures 2B and 2C), and NK cells
could not be primed for effector responses after TLR stim-
ulation (Figures 2D and 2E). In contrast, NK cells were
primed at day 5 after DT injection (Figures 2D and 2E),
when CD11chigh DCs had repopulated the spleen but506 Immunity 26, 503–517, April 2007 ª2007 Elsevier Inc.MZM and MM were still absent (Figures 2B and 2C). These
data exclude an important role of these macrophage pop-
ulations for NK cell priming. In agreement with these data,
NK cell effector functions in DC-ablated mice could be re-
stored by a single injection of 3–10 3 106 nontransgenic
DCs 2 days prior to microbial stimulation (Figure 2F). In
contrast, the same number of macrophages was unable
to rescue NK cell priming under these experimental condi-
tions (Figure 2F). Collectively, our data demonstrate that
CD11chigh DCs but not macrophages play a central and
nonredundant role for the priming of NK cell responses
in vivo.
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for NK Cell Priming
Recent in vitro studies with human NK cells suggested
that NK cell activation might be mediated by direct inter-
action with microbial products via NK cell-expressed
TLR (Hart et al., 2005; Schmidt et al., 2004; Sivori et al.,
2004). We investigated the contribution of NK cell-auton-
omous TLR signals for the priming of NK cells in response
to TLR ligands in mixed BM chimeric mice, in which the NK
cell compartment was derived in equal parts from TLR sig-
naling-deficient (myeloid differentiation factor 88,Myd88/,
or toll-like receptor adaptor molecule 1, Ticam1/) or com-
petent hematopoietic stem cells, which were distinguish-
able by a congenic marker. Injection of TLR ligands includ-
ing those entirely dependent on MyD88 (TLR9) or TICAM1
(TLR3) signaling led to efficient priming of both B6-derived
and TLR signaling-deficient NK cells, demonstrating that
NK cell-autonomous TLR signaling is not a requirement
for NK cell priming (Figure 3A). These data also rule out
an important contribution of IL-1 or IL-18 because their
cytokine receptors require MyD88 for signaling (Adachi
et al., 1998).
NK Cell Responses to Pathogens Require
the Presence of CD11chigh DC
The above findings led us to ask whether NK cell re-
sponses to pathogens would also require the presence
of CD11chigh DCs because infection of mice with viruses
(lymphocytic choriomeningitis virus [LCMV] and vaccinia
virus [VV]) that do not depend on DCs for their replication
and local infection with bacteria (Listeria monocytogenes)
resulted in potent priming of NK cells (Dunn and North,
1991; Welsh, 1978). Consistent with our data on TLR ago-
nists, we found that NK cell priming after infections was
strongly reduced in mice ablated of CD11chigh DCs (Fig-
ures 3B and 3C). During the first few days, local Listeria in-
fection is controlled by NK cell-derived IFN-g production
(Dunn and North, 1991). Here we showed that ablation
of CD11chigh DCs or depletion of all NK cells led to a similar
increase in pathogen load (Figure 3D), demonstrating that
potent NK cell responses to pathogens in vivo are critically
dependent on the presence of CD11chigh DCs.
Emergence of Peripheral Effector NK Cells
after Local Infection
Our in vivo findings are reminiscent of T cell priming, which
requires cognate interactions between T cells and DCs in
the LN draining infections (Banchereau and Steinman,
1998). After this interaction, T cells leave the LN via the ef-
ferent lymph and emerge as effector T cells in peripheral
organs (Masopust et al., 2001; Reinhardt et al., 2001). It
is unknown where the functionally relevant NK cell-DC in-
teractions take place during an infection and whether an
interaction of NK cells with DCs in LN or other secondary
lymphoid organs (i.e., spleen) would lead to the priming of
effector NK cells migrating to the periphery. To investigate
this issue, we studied NK cell recruitment and priming
after peripheral microbial challenge in an example sec-
ondary lymphoid organ, the LN, because it allows us tospecifically interfere with NK cell recruitment and to locally
restrict the microbial stimulus.
By using adoptive transfer of naive CD45.1+ spleno-
cytes into B6 mice (CD45.2+), we found that in the
Figure 3. NK Cell Responses to Pathogens Require DCs
(A) NK cells do not require cell-autonomous TLR-signaling for priming.
Mixed BM chimeric mice were generated by injecting lethally irradiated
mice with BM cells derived from the indicated TLR signaling-deficient
mouse strains or from B6 control mice expressing the indicated con-
genic markers. BM chimeric mice were injected 8–12 weeks later
with the indicated TLR ligands. IFN-g production of CD45.1+ (solid
bars) and CD45.2+ (open bars) NK cells was assayed in response to
RMA-S-H60 target cells 18 hr after TLR stimulation. Similar results
were obtained with RMA-S and YAC-1 targets (data not shown).
Shown are mean ± SD (n = 3–4), and results are representative of
two separate experiments.
(B and C) DC-ablated (open symbols) and control (solid symbols) mice
were infected with the indicated pathogens 12 hr after DT injection. NK
cell activation was analyzed 24 hr (Listeria) or 48 hr (LCMV and Vac-
cinia) later by determining cytotoxicity (B) and IFN-g production (C)
in response to RMA-S-H60 target cells. Similar results were obtained
with RMA-S and YAC-1 targets (data not shown). Shown are mean ±
SD (n = 3–4), and results are representative of three separate
experiments.
(D) NK cell-mediated control of local Listeria infection requires the
presence of DCs. Mice were depleted of NK cells by injection of
NK1.1 antibody 2 days prior to and at the day of infection. Control
mice received the same amount of mouse Ig. DCs were ablated by
DT injections 1 day before infection. Mice were infected subcutane-
ously with Listeria, and bacterial titers from the draining LN and spleen
were determined 1 day later. Each symbol represents results from an
individual mouse and bars represent the arithmetic mean. Results are
representative of two independent experiments.Immunity 26, 503–517, April 2007 ª2007 Elsevier Inc. 507
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(A and B) 1 day after DT injection, B6 mice (solid symbols) or CD11c DTR tg mice (open symbols) were injected subcutaneously (s.c.) into one footpad
with the indicated TLR ligand. NK cells were purified from the indicated organs, and IFN-g production (A) and cytotoxicity (B) was determined in re-
sponse to RMA-S-H60 cells 18–24 hr later. Similar results were obtained with YAC-1 and RMA-S target cells (data not shown). Shown are mean ± SD
(n = 3–4) and results are representative of three separate experiments.
(C and D) Blocking entry of NK cells into LN results in dramatically decreased numbers of effector NK cells in peripheral tissues. B6 mice were injected
with control Ig (Ctrl. Ig; solid symbols) or a CD62L antibody (open symbols) blocking entry of NK cells into the LN. 1 day later, mice were injected with
the indicated TLR ligands. Cytotoxicity (C) and IFN-g production (D) of NK cells purified from the indicated tissues in response to RMA-S-H60 cells
was determined 18–24 hr after local TLR stimulation. Similar results were obtained with RMA-S and YAC-1 targets (data not shown). Shown are
mean ± SD (n = 3–4), and results are representative of three separate experiments.
(E and F) Circulating naive NK cells need to enter the draining LN for priming. B6 mice (CD45.2+) were injected i.p. with control Ig (solid symbols) or
a CD62L antibody (open symbols). 2 hr later, 33 106 purified NK cells (CD45.1+) were injected i.v. followed by TLR stimulation 12 hr later. IFN-g pro-
duction (E) and granzyme B (gzmB) expression (F) of transferred CD45.1+ NK cells isolated from the indicated tissues in response to RMA-S-H60 cells
was determined by intracellular cytokine staining and electronic gating on NK cells 18–24 hr after local TLR stimulation. Similar results were obtained
with RMA-S and YAC-1 targets (data not shown). Shown are mean ± SD (n = 3–4) and results are representative of two separate experiments. nd, not
done.absence of inflammation (not shown) or in nondraining
(ND) LN, less than 1% of donor-derived lymphocytes are
NK cells (Figure S3A). During the first 4 hr after local TLR
stimulation, the proportion of donor-derived NK cells in
the DLN strongly increased whereas the proportion of T
cells did not significantly change (Figure S3A). Local TLR
stimulation led to an increase in LN cellularity (Figure S3B,
top). Although the total numbers of donor-derived lym-
phocytes and T cells in the DLN increased proportionally
(8- to 15-fold), the total number of NK cells increased by
one order of magnitude more (80- to 200-fold), demon-
strating that NK cells are strongly recruited to DLN early
after infection (Figure S3B). Similar results were obtained
by injection of TLR4, 7, 9 ligands or Listeria (data not
shown) and are supported by previous data investigating508 Immunity 26, 503–517, April 2007 ª2007 Elsevier Inc.the recruitment of NK cells to LN after local application
of TLR-stimulated BMDCs (Martin-Fontecha et al., 2004).
Similar to splenic NK cells (Figure 1 and Figure S2), rest-
ing NK cells isolated from LN, blood, liver, lungs, and bone
marrow had a naive phenotype (CD69low, CD25neg, gran-
zyme Blow) and did not display any effector functions
when incubated with target cells (Figure 4 and data not
shown). Local TLR stimulation led to the CD11chigh DC-
dependent priming of NK cells in the DLN but not the
NDLN (Figure 4A). Interestingly, as early as 8 hr after local
TLR stimulation, primed NK cells emerged in blood and
peripheral organs (Figures 4A and 4B). The emergence
of primed NK cells in the periphery did not occur in the ab-
sence of CD11chigh DCs. Collectively, these data demon-
strate that NK cells are recruited to secondary lymphoid
Immunity
Dendritic Cells Prime Natural Killer Cellsorgans draining microbial stimuli where they interact with
DCs and emerge after this interaction as effector cells in
the periphery.
NK Cell Priming Requires Entry of Naive NK Cells
into Secondary Lymphoid Organs
To directly address the question of whether the emer-
gence of peripheral effector NK cells requires entry of
naive NK cells into secondary lymphoid organs, we evalu-
ated the function of peripheral NK cells under conditions
that prevented NK cells from entering the DLN. NK cell en-
try into LN is dependent on the interaction of L-selectin
(CD62L) with its addressins on high endothelial venules
(Bajenoff et al., 2006; Chen et al., 2005). Blocking entry
of NK cells into LN by treatment with a CD62L antibody
prior to local microbial stimulation resulted in dramatically
decreased numbers of effector NK cells in peripheral tis-
sues (Figures 4C and 4D). To directly demonstrate that cir-
culating naive NK cells must enter the draining LN for
priming, we adoptively transferred highly purified, naive
NK cells (CD45.1+) into syngeneic CD45.2+ B6 mice prior
to local TLR stimulation. In control mice, transferred
CD45.1+ NK cells emerged as effector cells (IFN-g pro-
duction, granzyme B upregulation) in peripheral tissues
whereas NK cells prevented from migrating to the DLN
remained naive (Figures 4E and 4F). Thus, NK cells are re-
cruited to LNs draining microbial infections, and LN entry
and NK cell-DC interaction are required for the emergence
of primed NK cells in the periphery.
Type I IFN Signals Are Required for the Priming
of NK Cells
Previous studies employing in vitro coculture of NK cells
with BMDCs identified a variety of soluble factors pro-
duced by DCs that were able to enhance NK cell functions
(Andoniou et al., 2005; Fernandez et al., 1999; Krug et al.,
2004). In order to identify potential nonredundant signals
for the priming of NK cells in vivo, we investigated NK
cell priming in various mouse strains genetically deficient
for cytokines or cytokine signaling. NK cell priming in
response to all TLR ligands tested was unaffected by the
absence of IFN-g, the IFN-g receptor, or CD40 (data not
shown). Although IFN-g production was reproducibly
reduced in response to some microbial stimuli (TLR4,
TLR9, Listeria), IL-12-deficient mice allowed for substan-
tial priming of NK cell responses (Figure S4). In addition,
stimulation of highly purified NK cells with recombinant
IL-12 in vitro did not lead to efficient priming of NK cells
for killing (Figure 5A) or IFN-g production (Figure 5B). Col-
lectively, these data suggest that IL-12 is not required for
NK cell priming but can potently enhance IFN-g produc-
tion of primed NK cells.
In contrast, the type I IFN receptor (IFNAR) was required
for the priming of NK cells in response to all TLR ligands
and pathogens tested, demonstrating a central role of
this signaling pathway (Figures 5C–5E). Although IFNAR
was absolutely required for NK cell cytotoxicity (Figure 5C)
and the upregulation of granzyme B expression (Fig-
ure 5E), residual, albeit substantially reduced, IFN-gresponses were elicited in response to Listeria infection
and to TLR4 and TLR9 stimulation (Figure 5D). Thus, NK
cell priming largely depends on a functional type I IFN-
signaling pathway.
NK Cell-Autonomous Type I IFN Signaling
Is Not Required for NK Cell Priming
We investigated whether NK cell priming requires the rec-
ognition of type I IFNs by NK cells. To this end, we trans-
ferred Ifnar/ or Ifnar+/+ NK cells (CD45.2+) into Ifnar+/+
mice (CD45.1+) and analyzed NK cell priming after TLR
stimulation. Interestingly, NK cell priming was indepen-
dent of the presence of IFNAR on NK cells (Figures 6A
and 6B), and incubation of highly purified naive NK cells
with graded doses of type I IFNs in vitro failed to enhance
NK cell effector functions (Figures 5A and 5B). Thus, type I
IFN signals are required for NK cell priming in response to
pathogens, but type I IFNs do not prime NK cells directly.
To investigate type I IFN effects on DCs leading to the
priming of NK cells, we employed an in vitro coculture sys-
tem of BM-derived DCs and highly purified NK cells. In an
extension of previous work (Andoniou et al., 2005; Fer-
lazzo et al., 2004), we found that TLR-stimulated (Fig-
ure 6C) and anti-CD40-stimulated (Figure 6D) but not
unstimulated BMDCs primed NK cells. However, these
stimuli had no direct effect on NK cells (Figure 6C). Con-
firming our in vivo findings, priming of NK cells by stimu-
lated DCs required the presence of the type I IFN receptor
on DCs but not NK cells (Figure 6C) and was abrogated in
the presence of blocking antibodies to type I IFNs (Fig-
ure 6D, top). Type I IFN stimulation of BMDCs was suffi-
cient to prime NK cells (Figure 6C). These data demon-
strate that TLR stimulation of BMDCs induces type I IFN
production and that the response to the type I IFN signal
by DCs (but not NK cells) is required for the priming of
NK cells (Figures 5, 6C, and 6D).
IL-15 Is Required and Sufficient for NK Cell
Priming In Vivo
Because type I IFNs did not directly prime NK cells, we
wanted to identify the molecular signal(s) induced by
type I IFNs leading to NK cell priming. It has been sug-
gested that type I IFNs and CD40 stimulation induce the
production of IL-15 by DCs (Jinushi et al., 2003b; Ko-
schella et al., 2004; Mattei et al., 2001; Nguyen et al.,
2002; Zhang et al., 1998). In support of a central role for
IL-15 in the priming of NK cells, TLR- or type IFN-stimu-
lated BMDCs derived from Il15/ mice were unable to
prime NK cells (Figure 6C, bottom), and neutralization of
IL-15 (but not IL-2) during coculture of TLR-stimulated,
anti-CD40-stimulated (Figure 6D), or type I IFN-stimulated
(Figure 6E) DCs with NK cells strongly reduced NK cell
priming. Thus, type I IFN-induced IL-15 is required for
the priming of NK cell responses.
Previous work showed that IL-15 is trans-presented on
the surface of IL-15-producing cells in complex with
IL-15Ra, which created an IL-15 gradient and confining
the action of IL-15 (Dubois et al., 2002; Koka et al.,
2004). This is in agreement with our observation thatImmunity 26, 503–517, April 2007 ª2007 Elsevier Inc. 509
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Dendritic Cells Prime Natural Killer CellsFigure 5. Priming of NK Cells in Response to Infections Requires Type I IFN Signaling and IL-15
(A and B) IL-15 is sufficient to prime NK cells in vitro. Highly purified NK cells were incubated overnight with the indicated cytokines. Cytotoxic activity
of NK cells (A) and IFN-g production (B) was determined in response to RMA-S-H60 target cells. Similar results were obtained with RMA-S and YAC-1
targets (data not shown). The numbers in the histograms (B) represent the percentage of IFN-g+ NK cells as determined by intracellular cytokine stain-
ing. IFN-I, type I IFNs.
(C–E) NK cell priming requires type I IFN signaling. B6 (solid symbols) or Ifnar/ mice (open symbols) were injected with the indicated TLR ligands or
pathogens and cytotoxicity (C) or IFN-g production (D) in response to RMA-S-H60 target cells and (E) granzyme B (gzmB) expression by NK cells were
assayed 18 hr later. Similar results were obtained with RMA-S and YAC-1 targets (data not shown). Shown are mean ± SD (n = 4) and results are
representative of five separate experiments.IL-15-dependent priming of NK cells by DCs in vitro was
cell-cell contact dependent under our experimental condi-
tions (Figure 6F). TLR or type I IFN stimulation led to the
type I IFN-dependent upregulation of IL-15Ra expression
by DCs in vivo (Figure 7A) and in vitro (Figure 7B; Koka
et al., 2004). Direct stimulation of DCs with a CD40
antibody in vivo also resulted in the type I IFN-dependent
upregulation of IL-15Ra (Figure 7A).
Although NK cells (CD45.1) transferred into an IL-15-
competent environment (CD45.2) were primed after
TLR3, 4, or 9 stimulation or direct triggering of the CD40
receptor, NK cells transferred into IL-15-deficient mice
(CD45.2) were not (Figure 7D). Priming of NK cells in
Il15/mice could be completely restored in vivo by i.p. in-
jection of IL-15 at the time of TLR or anti-CD40 stimulation
(Figures 7E and 7F, IL-15 i.p.). Although IL-15 is required
for the survival of NK cells (Cooper et al., 2002; Kennedy
et al., 2000; Prlic et al., 2003), the number of donor-derived
functional and nonapoptotic NK cells recovered from the
Il15/ environment remained comparable to the number
of donor-derived NK cells from an Il15+/+ environment
(Figure 7C), if the duration of the experiment was short
(4–8 hr). In addition, donor-derived NK cells isolated
from Il15/ mice were fully functional in vitro when510 Immunity 26, 503–517, April 2007 ª2007 Elsevier Inc.IL-15 was added to the cultures during the IFN-g assay
(Figures 7E and 7F, IL-15 in vitro), providing further evi-
dence that the lack of NK cell priming in Il15/ mice is
not reflective of defective NK cells. Our data demonstrate
that NK cells are primed by IL-15 trans-presented on
IL-15Ra+ DCs, expression of which are induced by type
I IFNs produced in response to microbial stimulation. Be-
cause IL-15 was the only cytokine able to efficiently prime
NK cells in vitro (Figures 5A, 5B, and 6C–6E), we conclude
that type I IFN-induced IL-15 constitutes the central signal
required in vivo for the priming of NK cells in response to
infections.
DISCUSSION
Here we report that potent antimicrobial NK cell re-
sponses to all viral and bacterial infections tested require
the interaction of NK cells with CD11chigh DCs in second-
ary lymphoid organs. Our data support a model in which
NK cells undergo a process of priming that rapidly initiates
a molecular program, endowing them with effector func-
tions. We chose to term this process ‘‘priming’’ because
in most cases NK cells were not activated when interact-
ing with DCs in situ (i.e., they do not produce IFN-g) but,
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(A and B) NK cell priming does not require NK cell-autonomous type I IFN signaling. Purified CD45.2+ B6 (solid bars) or CD45.2+ Ifnar/NK cells (open
bars) were transferred i.v. into CD45.1+ B6 recipients. 1 day later, mice received i.p. injections of PBS or the indicated TLR ligands, and (A) IFN-g
production of CD45.2+ NK cells in response to RMA-S-H60 cells and (B) granzyme B (gzmB) expression by donor NK cells was assayed 18–24 hr
after TLR stimulation. Similar results were obtained with YAC-1 targets (data not shown). Shown are mean ± SD (n = 3–4) and results are represen-
tative of three separate experiments.
(C) Highly purified NK cells were cultured in either the presence (solid squares) or absence (open squares) of BMDCs from the indicated mouse strains
stimulated as indicated. Lysis of RMA-S-H60 cells by NK cells was determined 12 hr later. Similar results were obtained with RMA-S and YAC-1
targets (data not shown). IFN-I, type I IFNs.
(D and E) BMDCs from B6 mice were stimulated with the indicated TLR ligands, an agonistic CD40 antibody (D) or with type I IFNs (E) and cocultured
with NK cells in the presence of control serum (solid squares) or antisera specific for the indicated cytokines (open squares). NK cell cytotoxicity
against RMA-S-H60 target cells was determined 12 hr later. Similar results were obtained with RMA-S and YAC-1 targets (data not shown). IFN-I,
type I IFNs.
(F) Cytotoxicity of NK cells either cocultured with type I IFN-stimulated DCs in the same well (solid squares) or spatially separated (open squares) by
a membrane (0.4 mm pores) was assayed against RMA-S-H60 cells. Similar results were obtained with YAC-1 targets (data not shown). Results (C–F)
are representative of at least three independent experiments. IFN-I, type I IFNs.unlike naive NK cells, were able to recognize cells ex-
pressing stimulatory ligands. We have carefully compared
the functional properties of freshly isolated NK cells from
primary (bone marrow) and secondary (spleen, LN) lym-
phoid organs, blood, and peripheral tissues (lung, liver).
Contradicting the idea of a sizeable population of locally
restricted, ‘‘naturally active’’ NK cells, NK cells from all or-
gans tested displayed a naive phenotype, and the fraction
of NK cells directly triggered by various potent target cells
in vitro was negligible (<5%). In contrast to human NK cells
(Bryceson et al., 2006), naive NK cells from mice are not
appreciably activated by target cells (e.g., YAC-1) known
to express ligands for two or more stimulatory immuno-
receptors (Jamieson et al., 2002; Pessino et al., 1998).
Our ADCC experiments demonstrated that CD16-medi-
ated amplification of NK cell responses also requires prim-ing of NK cells. Our data strongly support the concept that
resting NK cells in mice are naive lymphocytes that require
a priming event to obtain full effector functions.
A potential role of DCs for NK cell activation was inferred
from in vitro coculture experiments employing TLR-stimu-
lated or infected BM- or monocyte-derived DCs or macro-
phages (Andoniou et al., 2005; Chambers et al., 1996;
Ferlazzo et al., 2004; Fernandez et al., 1999; Gerosa
et al., 2002; Jinushi et al., 2003a; Koka et al., 2004; Krug
et al., 2004). Although a potential role of endogenous
DCs for the in vivo activation of NK cells has been exten-
sively discussed on the basis of these in vitro data, no data
were available analyzing NK cell effector functions in vivo
(cytotoxicity, cytokine production, antimicrobial activity) in
the absence of DCs. A previous report that used depletion
of all CD8a+ cells including CD8aa+ DCs found that at dayImmunity 26, 503–517, April 2007 ª2007 Elsevier Inc. 511
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redundant Priming Signal for NK Cells
(A and B) IL-15Ra expression (shaded histo-
grams) by splenic DCs 24 hr after TLR or anti-
CD40 stimulation in vivo (A) or by BMDCs 24
hr after in vitro stimulation (B). Open histo-
grams represent staining with control Ig. The
numbers indicate the percentage of IL-15Ra+
CD11chigh MHC-II+ cells. Data are representa-
tive of at least three independent experiments.
(C) Highly purified CD45.1+ NK cells were in-
jected into either CD45.2+ B6 or CD45.2+
Il15/ mice. The percentage of annexin V
CD45.1+ NK cells (in the lymphocyte gate)
recovered from the spleens of B6 or Il15/
mice 6 hr after transfer are indicated. Data
are representative of five independent experi-
ments.
(D–F) Highly purified CD45.1+ NK cells were in-
jected i.v. into either CD45.2+ B6 (solid bars) or
CD45.2+ (open bars) Il15/ mice. Mice were
injected 2 hr later with the indicated TLR li-
gands or anti-CD40. Control mice received
injections of PBS or control Ig (Ctrl. Ig), respec-
tively. IFN-g production of gated CD45.1+ NK
cells against RMA-S-H60 target cells was
determined 4 hr after TLR stimulation by intra-
cellular cytokine staining and electronic gating
on donor NK cells. Some Il15/ mice received
i.p. injections of 4 mg IL-15 at the time of TLR
stimulation (IL-15 i.p.). In some experiments,
10 ng/ml IL-15 was added during the in vitro re-
stimulation of donor NK cells with RMA-S-H60
target cells required for the determination of in-
tracellular cytokine expression (IL-15 in vitro).
Similar results were obtained with RMA-S or
YAC-1 target cells (data not shown). Shown
are mean ± SD (n = 3) and data are representa-
tive of at least three independent experiments.
nd, not done.6 after MCMV infection, the accumulation of Ly49H+ NK
cells was reduced (Andrews et al., 2003) but did not in-
clude an analysis of NK cell effector functions. DC-ablated
CD11c DTR tg mice infected with herpes simplex virus
type 1 (HSV-1) showed decreased survival, implicating
defective T and NK cell responses (Kassim et al., 2006).
Our data provide definitive evidence that NK cell effector
responses require the in vivo interaction of NK cells with
CD11chigh DCs.
It was unknown where the priming of NK cells by DCs
occurs. It has been proposed that functionally relevant in-
teractions between NK cells and DCs occur in peripheral
tissues (Moretta, 2002). Others suggested NK cell/DC in-
teractions in secondary lymphoid organs, where immune
responses are believed to be initiated (Bajenoff et al.,
2006; Chen et al., 2005; Ferlazzo et al., 2004; Martin-Fon-
techa et al., 2004). Our data demonstrate that after local
infection or TLR stimulation, NK cells are recruited to the
DLN where they are primed by CD11chigh DCs. Once
primed in the local LN, NK cells emerge as effector cells
in blood and peripheral tissues. Blocking of LN entry abro-
gated the appearance of primed NK cells in the periphery,
ruling out the possibility that systemic TLR effects are re-512 Immunity 26, 503–517, April 2007 ª2007 Elsevier Inc.sponsible for the priming of peripheral NK cells. It must be
noted that NK cell priming is likely to also occur in other
secondary lymphoid organs (e.g., spleen). Our data indi-
cate that NK cells, like T cells, leave secondary lymphoid
organs after their interaction with DCs and preferentially
migrate to peripheral organs to battle diseased cells.
The precise mechanism by which DCs prime NK cells
was unknown. A previous in vitro study by Koka et al. in-
dicated that LPS stimulation of BM-derived DCs led to in-
creased expression of IL-15Ra on BMDCs, which was re-
quired for IFN-g production and cytotoxicity by NK cells
after in vitro coculture with BMDCs (Koka et al., 2004).
We provide evidence that IL-15 produced by DCs in re-
sponse to microbial stimulation or direct CD40 triggering
and its presentation on IL-15Ra to NK cells is required
and sufficient for NK cell priming in vivo. Our data suggest
that the reported TLR-induced IL-15 production by DCs is
indirect and requires type I IFN production and signaling.
Our findings are supported by data showing that NK cells
derived from uninfected mice constitutively overexpress-
ing IL-15 (IL-15 tg mice) display a primed phenotype
whereas NK cells from non-tg littermates are naive (Feh-
niger et al., 2001). It is intriguing that IL-15-expressing
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IL-15 can be expressed by many cells including other leu-
kocytes and epithelial cells (Shinozaki et al., 2002; Wald-
mann et al., 2001). The central role of CD11chigh DCs for
NK cell priming is likely attributable to their unique ability
to create a locally confined niche of intimate NK cell/DC
contact in secondary lymphoid organs (Bajenoff et al.,
2006) and to their immediate upregulation of both IL-15
and IL-15Ra expression after infections. Our data do not
rule out that IL-15-expressing cells other than DCs might
play an important role for NK cell homeostasis or for the
maintenance of NK cell responses under conditions of
chronic inflammation, which are frequently associated
with increased IL-15 expression by epithelial cells (Shino-
zaki et al., 2002). Our data indicate that the IL-15/IL-15Ra
system functions as a rheostat to regulate distinct aspects
of NK cell function. Constitutive expression of IL-15/IL-
15Ra is required for the survival of NK cells while type I
IFN-induced upregulation of IL-15/IL-15Ra by DCs is in-
dispensable for their priming. Intriguingly, very high levels
of DC-derived IL-15 have been recently implicated in the
development of immunopathology (Ohteki et al., 2006).
We have identified type I IFNs as the principal inducer of
IL-15 production by DCs after TLR stimulation or bacterial
and viral infections in vivo. This is supported by previous
studies suggesting that type I IFNs can induce IL-15 pro-
duction by myeloid cells (Jinushi et al., 2003b; Mattei et al.,
2001) and by data indicating that type I IFN-dependent
IL-15 production is required for the accumulation of NK
cells after MCMV infection (Nguyen et al., 2002). Although
type I IFNs are long known to be potent inducers of NK cell
activation (Djeu et al., 1979; Gidlund et al., 1978), our data
demonstrate that NK cell-autonomous type I IFN signaling
is not required for NK cell priming. Instead, priming of NK
cells for cytotoxicty and cytokine production requires
a functional type I IFN-signaling pathway within DCs. An
unresolved question is the source of type I IFNs after
TLR stimulation or infection. Previous work suggested
a central role of pDC-derived type I IFNs in NK cell activa-
tion after MCMV infection (Dalod et al., 2003; Krug et al.,
2004). Although specific depletion of pDCs in vivo led to
reduced type I IFN production after MCMV infection, NK
cell responses were not impacted because increased
IL-12 production by myeloid DCs could compensate for
the reduced availability of type I IFNs (Krug et al., 2004).
Our data demonstrate that the central role of CD11chigh
DCs for NK cell priming is their unique ability to quickly
respond to pathogen-induced type I IFN production with
enhanced expression of IL-15Ra and IL-15.
Other cytokines, although not absolutely required for
NK cell priming, might increase NK cell activity when
IL-15/IL-15Ra levels are limiting, which is supported by
the observation that IL-12 and IL-15/IL-15Ra act synergis-
tically in activating cytokine production by NK cells in vitro
(Koka et al., 2004). Specifically, the limited role of DC-
derived IL-12 for IFN-g production in vivo was unex-
pected, but the majority of data indicating a nonredundant
role of IL-12 for IFN-g production by NK cells were ob-
tained from in vitro experiments (Andoniou et al., 2005;Ferlazzo et al., 2004; Krug et al., 2004). In agreement
with previous reports, we detected a reduction of IFN-g
production in IL-12-deficient mice in response to certain
stimuli (TLR4, TLR9, Listeria) (Tripp et al., 1993). However,
when compared to type I IFNs or IL-15, the requirement of
IL-12 for IFN-g production by NK cells was less absolute.
This is supported by our in vitro data showing that direct
stimulation of highly purified naive NK cells with IL-12
did not elicit substantial IFN-g responses.
In many ways, NK cell priming resembles the priming of
T lymphocytes. However, NK cell priming does not gener-
ally require proliferation of distinct NK cell clones (data not
shown). The molecular signals required for NK cell priming
and bystander proliferation of T lymphocytes after viral
infection or CD40 stimulation are strikingly similar
(Koschella et al., 2004; Lodolce et al., 2001; Tough et al.,
1996; Zhang et al., 1998). Although IL-15 is indispensable
for NK cell priming, it might be vestigial for the priming of T
lymphocytes. Together with data from other groups dem-
onstrating that NK cells undergo an education process
that has been compared by some to ‘‘positive selection’’
of T cells (Anfossi et al., 2006; Fernandez et al., 2005;
Kim et al., 2005), and a recent report indicating that NK
cells are capable of immunological ‘‘memory’’ (O’Leary
et al., 2006), NK cells appear to be much more related to
lymphocytes of the adaptive immune system than previ-
ously appreciated. These results have important implica-
tions for the development of immunotherapeutic strate-
gies aiming to boost NK cell effector functions.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 (B6), BALB/c, and B6-Ly5.2/Cr (CD45.1+) mice were ob-
tained from the NCI-Frederick Animal Production Program. Il15/
mice (Kennedy et al., 2000) were purchased from Taconic. Rag1/,
Myd88/ (Adachi et al., 1998), and CD11c DTR tg (Jung et al., 2002)
mice (all on a C57BL/6 background) were a kind gift of D. Littman
(New York University, New York, NY). CD11c DTR tg mice were back-
crossed 10–15 generations to C57BL/6. Rag1/ CD11c DTR tg mice
were generated by crossing Rag1/ mice to CD11c DTR tg mice.
Ifnar/ mice (Muller et al., 1994) backcrossed 12 generations to
C57BL/6 were generated by J. Sprent and M. Rubinstein (The Scripps
Research Institute, La Jolla, CA) and kindly provided by J. Ernst and
A. Wolf (New York University). Il12p35/p40/ mice on a B6 back-
ground and Il12p35/ mice (Magram et al., 1996) on a BALB/c back-
ground were kindly provided by C. Bogdan (Universita¨t Freiburg,
Germany). Mice were used at 8–16 weeks of age. All experiments
were approved by and in accordance with the local animal care and
use committees.
Stimulation of DCs and Determination of Bacterial Loads
Mice were injected i.p. or s.c. with TLR ligands (TLR3, 50 mg or 5 mg
poly(I:C) [Sigma]; TLR4, 25 mg or 1 mg ultrapure LPS from E. coli
O111:B4 [Invivogen]; TLR7, 250 mg or 25 mg R837 [Invivogen]; TLR9,
125 mg or 10 mg CpG1668 synthesized by Invitrogen) or with an agonis-
tic antibody specific for CD40 (100 mg 1C10 [eBioscience]). Control
mice received injections of PBS or 100 mg isotype control antibody
(rat IgG2a). Mice were injected with 104 cfu L. monocytogenes strain
EGD i.v. or s.c. To determine bacterial titers in LN and spleen, organs
were homogenized in 1 ml of PBS, and serial dilutions of the homoge-
nates were plated on BHI agar plates. Colonies were counted after
incubation at 37C for 24 hr. For viral infections, mice were infectedImmunity 26, 503–517, April 2007 ª2007 Elsevier Inc. 513
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by H. Pircher, Universita¨t Freiburg).
DC Ablation
CD11chigh DCs were ablated by a single injection of 2–4 ng DT (Sigma
or Calbiochem)/g body weight (Jung et al., 2002). Ablation of DCs was
confirmed by staining for CD11chigh MHC-II+ cells in spleen and LN.
Routinely, we observed a >95% reduction of CD11chigh DCs. In
some experiments, CD11c DTR tg mice were injected i.v. with 3–
10 3 106 BMDCs or peritoneal macrophages from non-tg mice
1 day prior to DT application.
Preparation of Lymphocyte and Myeloid Cell Populations
Blood samples were collected by heart bleed. Red blood cells were
lysed with the BD PharmLyse solution (BD Biosciences). For liver
lymphocyte preparation, total liver cells were resuspended in 40%
isotonic Percoll (GE Healthcare), layered upon an 80% Percoll solution,
and centrifuged at 900 3 g. Mononuclear cells were harvested from
the 40/80% interphase and extensively washed thereafter. For
lymphocyte isolation from the lungs, organs were perfused through
the right ventricle with 20 ml PBS. Lung tissue was cut into small pieces
and incubated for 45 min at 37C in Hank’s balanced salt solution
(HBSS; Invitrogen) containing 1 mg/ml collagenase D (Roche). Total
lung cells were layered upon Lympholyte (Cedarlane) and centrifuged
at 8003 g, and lymphocytes were recovered at the interphase. Where
indicated, NK cells were positively selected by magnetic enrichment of
DX5+ cells (Miltenyi Biotec) followed by sorting of DX5+CD3 cells on
a MoFlo cell sorter (Dako). The purity of NK cells was generally be-
tween 95% and 99%. BMDCs were obtained by culture of BM cells
for 5–6 days in 10 ng/ml GM-CSF (Peprotech). Peritoneal exudate
macrophages were isolated 4 days after i.p. injection of 1.5 ml of 4%
Brewer’s thioglycolate broth (Difco).
Immunohistology
Cryostat tissue sections (5 mm) were thawed onto slides, air-dried, and
fixed with acetone. Sections were blocked (10% FCS and 10 mg/ml
anti-FcgRI/II) and stained with biotinylated antibodies specific for
CD11c (N418, BD Biosciences), ER-TR9, MOMA-1 (both BMA Bio-
medicals) visualizing marginal zone and metallophilic macrophages,
respectively, or F4/80 (Caltag), CD11b (M1/70, BD Biosciences)
visualizing red pulp macrophages. Immunophosphatase stain was
performed by adding streptavidin-alkaline phosphatase and Vector
Red Alkaline Phosphatase reagent (Vector Laboratories). Sections
were counterstained with hematoxylin.
Antibody Blocking and Depletion
NK cells were depleted by injection of 200 mg of purified NK1.1 anti-
body or by injection of 50 ml asialo-GM1 antiserum (Wako Chemicals)
2 days prior and at the day of microbial stimulation. The NK1.1 anti-
body was purified from hybridoma supernatants (PK136, ATCC HB-
191) in our laboratory according to standard procedures. Control
mice received injections of the same amount of normal mouse IgG
or rabbit IgG (Jackson ImmunoResearch Laboratories). Depletion of
NK cells was confirmed at the day of the experiment by flow cytometry
analysis with noncompeting antibodies (costaining with DX5/CD49b,
CD122, and CD3). In general, less than 2% of the depleted cell popu-
lation could be detected. For blocking of lymphocyte entry into LN,
mice were injected with 200 mg CD62L antibody (Mel14; eBioscience)
1 day prior to the injection of microbial stimuli or transfer of cell popu-
lations. Control animals received the same amount of normal IgG.
1 day later, mice were injected with the indicated TLR ligands and
NK cell priming was evaluated.
Ex Vivo Analysis of NK Cell Function
IFN-g production by NK cells was determined by intracellular cytokine
staining. Highly purified NK cells (0.1–0.2 3 106) or splenocytes
(0.25–1 3 106) were incubated on plates coated overnight with the514 Immunity 26, 503–517, April 2007 ª2007 Elsevier Inc.indicated concentrations of purified antibodies (all from eBioscience)
or with the indicated target cell lines for 4–6 hr in the presence of
2 mM monensin (GolgiStop, BD Biosciences) or 10 mg/ml brefeldin
A (Sigma). After cell-surface staining with monoclonal antibodies
specific for NK1.1 or DX5/CD49b and CD3, cells were fixed and
permeabilized with the Cytofix/Cytoperm reagent (BD Biosciences)
followed by intracellular IFN-g staining. Results represent percent of
gated NK1.1+ or CD49b/DX5+ CD3 cells producing IFN-g. Accumula-
tion of granzyme B was analyzed by intracellular staining with a 1:750
dilution of a rabbit serum specific for mouse granzyme B or rabbit
preimmune serum (kind gift of M. Simon, Max-Planck-Institut fu¨r
Immunbiologie, Freiburg, Germany) followed by a fluorochrome
labeled goat anti-rabbit antibody (2.5–5 mg/ml, Molecular Probes).
Cytotoxicity of NK cells against the indicated target cells was deter-
mined in a standard 4 hr 51chromium release assay. For the ADCC as-
says, 51Cr-labeled RMA cells were incubated for 30 min on ice with
20–50 mg/ml Thy1.2 (BD Biosciences) or isotype control antibody (rat
IgG2b, eBioscience). Target cells were washed and mixed with ef-
fector cells. The percentage of NK1.1+CD3 cells in the lymphocyte
populations was determined prior to the cytotoxicity assays, and lym-
phocyte numbers were adjusted to contain the same number of NK
cells. Thus, an NK cell:target ratio of 6:1 is equivalent to a 100–200:1
splenocyte:target ratio. Data from all assays are given as the mean
of triplicate measurements. Standard deviations were generally less
than 6% and were in most cases omitted from the figures for reasons
of clarity.
In Vitro Assays for NK Cell Priming
Highly purified NK cells were stimulated for 12–18 hr with the indicated
concentrations of cytokines (IL-12, R&D Systems; type I IFN, IFN-aA,
and IFN-b, PBL Biomedical Laboratories; IL-15, Peprotech). BMDCs
were stimulated with TLR ligands (TLR3, 25–50 mg/ml poly(I:C);
TLR9, 25–50 mg/ml CpG1668), type I IFNs (100–1000 U/ml purified
type I IFN [kind gift of I. Gresser] or 100–1000 U/ml each of recombi-
nant mouse IFN-aA and IFN-b [PBL Biomedical Laboratories]), or
anti-CD40 (20–50 mg/ml). Highly purified NK cells (1–23 106) were cul-
tured for 12 hr alone or with 106 stimulated BMDCs as indicated. In
some experiments, coculture was performed by spatially separating
BMDCs and NK cells in transwell plates (Costar). DC-derived type I
IFNs were neutralized with 100–1000 neutralizing units of sheep anti-
mouse IFN-a/b immunoglobulin (Gidlund et al., 1978) (kind gift of I.
Gresser) or 10–50 mg/ml each of neutralizing rat monoclonal antibodies
to IFN-a and IFN-b (PBL Biomedical Laboratories). Control wells con-
tained control sheep immunoglobulin or an isotype control antibody
(rat IgG1, eBioscience). IL-15 and IL-2 were neutralized with goat
antisera against mouse IL-15 (50 mg/ml) or mouse IL-2 (50 mg/ml;
R&D Systems). After 12–18 hr of stimulation, NK cells were harvested
and analyzed in a standard 4 hr 51Cr release assay.
Bone Marrow Chimeric Mice
Mice were lethally irradiated (12 Gy) and injected i.v. with 2–53 106 BM
cells derived from the indicated mouse strains. BM chimeric mice were
analyzed 8–12 weeks after transplantation. Chimerism was evaluated
prior to the experiments by analyzing blood leukocytes. Chimeras
used in the functional experiments had <2% of remaining host leuko-
cytes and showed even engraftment (50% ± 12%) for the mixed BM
chimeras. The observed differences in engraftment after transfer of
mixed BM were random, demonstrating that BM cells from the indi-
cated mouse strains were not genetically impaired in reconstituting
the hematopoietic pool.
NK Cell Transfers
For the transfer of NK cells, 2–5 3 106 purified splenic NK cells were
injected i.v. into the indicated hosts. In some of the experiments that
used Il15/ mice as hosts, 4 mg of recombinant IL-15 (Peprotech)
was injected at the time of TLR stimulation to rescue NK cell function.
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To assess the recruitment of circulating lymphocytes to LN, 20–50 3
106 CD45.1+ splenocytes were injected i.v. into CD45.2+ B6 mice.
2 hr later, mice were challenged s.c. into the footpad with the indicated
microbial stimuli. At the indicated time points, LN were harvested and
the proportion of donor-derived NK cells and T cells in the LN was
determined by electronic gating on the CD45.1+NK1.1+CD3 or
CD45.1+NK1.1CD3+ population, respectively. Absolute numbers of
donor-derived T and NK cells were calculated based on the total num-
ber of cells per LN.
Flow Cytometry Analysis
Staining of cells was performed with FITC-conjugated antibodies spe-
cific for mouse CD33 (145-2C11), CD25 (PC61.5), Ly49A (A1), Ly49C/I
(5E6), Ly49D (4E5), Ly49G2 (Cwy-3), NKG2A/C/E (20d5), CD122 (TM-
b1), CD45.1 (A20), CD45.2 (104), class II MHC (M5/114.15.2), IFN-g
(XMG1.2), PE-conjugated antibodies specific for mouse CD19 (6D5),
CD69 (H1.2F3), NKR-P1B/C (PK136), CD45.1 (A20), CD45.2 (104),
CD49b (DX5), CD122 (TM-b1), PDCA-1 (Miltenyi) or class II MHC
(M5/114.15.2), PerCP-conjugated antibody to mouse CD33 (145-
2C11) or CD45R/B220 (RA3-6B2, BD Biosciences) or allophycocyanin
(APC)-conjugated antibodies specific for mouse CD33 (145-2C11),
CD11b (M1/70), CD11c (N418), CD45.1 (A20), NKR-P1B/C (PK136),
and IFN-g (XMG1.2) (all from eBioscience unless stated differently).
IL-15Ra expression by DCs was analyzed by staining with a biotiny-
lated goat anti-mouse IL-15Ra antibody (R&D Systems) or a biotiny-
lated normal goat Ig and electronic gating on CD11chigh MHC-II+ cells.
When staining cells from CD11c DTR tg mice, FITC-conjugated anti-
bodies were excluded from the characterization of GFP+ cells
(CD11chigh DCs). All flow cytometry data were acquired on a FACS-
Calibur cytometer (BD Biosciences) with CellQuest software (BD Bio-
sciences) and analyzed with FloJo software (Tree Star, Inc).
Supplemental Data
Four supplemental figures can be found with this article online at http://
www.immunity.com/cgi/content/full/26/4/503/DC1/.
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